![]() |
![]() |
![]() |
|||
![]()
|
Issues archive
|
Home » News » Ashland to Explore Strategic Alternatives for Composites and for BDO Manufacturing Facility in Marl, Germany
![]() Ashland announced it will explore strategic alternatives for its Composites segment, as well as for the butanediol (BDO) manufacturing facility in Marl, Germany, and related merchant Intermediates and Solvents (I&S) products. Ashland intends to evaluate all options with respect to these assets, including a potential sale. The company plans to retain its BDO plant in Lima, Ohio, to ensure consistent supply for Ashland's internal needs. The company expects to use proceeds from a possible sale of these assets primarily for debt reduction and share repurchases. Ashland's board of directors has approved a new $1 billion share repurchase authorization to provide flexibility. The new authorization replaces the previous authorization which had approximately $500 million remaining. Ashland intends to take action to eliminate stranded costs from a potential sale, consistent with similar past transactions. If Ashland decides to sell these assets, it would expect to sign an agreement by the end of calendar 2018. Ashland has retained Citi to assist in this strategic review process.
All rights reserved. No information from the web site may be reproduced without the permission of the magazine's editorial board.
© Eurasian chemical market, 2005-2023 |
|||